Exelixis is a biotechnology company that develops and commercializes small molecule inhibitors of signal transduction pathways. Our mission is to develop and commercialize innovative medicines that improve patient outcomes.
This key role drives consistency across QA systems and processes for the Clinical QA team, identifying issues and risks, escalating in a timely fashion, and aligning metrics that provide input into a compliance scorecard for Clinical programs.
Exelixis is a biotechnology company that develops and commercializes small molecule inhibitors of signal transduction pathways. Our mission is to develop and commercialize innovative medicines that improve patient outcomes.
Exelixis